Sat Kartar Life Limited (NSEI: SATKARTAR)
Health Care · Pharmaceuticals · IN
Rs136.60
-25.80% today · -13.4% 1Y
Sat Kartar Life Limited (NSEI: SATKARTAR) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $22.22M.
Over the last twelve months the share price has lost 13.4%, trading between 110.30 and 219.80.
Tweenvest scores Sat Kartar Life Limited across four factors: quality 69/100, value 73/100, growth 100/100, dividend 11/100. Its strongest factor is growth.
SATKARTAR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $22.22M
- Revenue (TTM)
- $21.40M
- P/E
- 12.58
- EPS
- 10.86
- Dividend yield
- 0.51%
- Beta (5Y)
- —
- 52-week high
- Rs219.80
- 52-week low
- Rs110.30
- Avg volume (3M)
- —
- Shares outstanding
- 15.74M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| BCWORLD PHARM. Co., Ltd.KOSDAQ: A200780 | $22.96M | ₩3,020.00 | -0.98% |
| Sanjivani Paranteral LimitedBSE: 531569 | $22.88M | Rs180.25 | +9.18% |
| Optimi Health Corp.CNSX: OPTI | $22.87M | CA$5.70 | -10.94% |
| Provectus Biopharmaceuticals, Inc.OTCPK: PVCT | $22.23M | $0.05 | -2.76% |
| Neurothera Labs Inc.TSXV: NTLX | $22.17M | CA$2.30 | -47.73% |
| Aytu BioPharma, Inc.NasdaqCM: AYTU | $22.01M | $2.02 | -0.25% |
| Accretion Pharmaceuticals LimitedNSEI: ACCPL | $21.70M | Rs188.95 | -7.06% |
| Accretion Nutraveda LimitedBSE: 544694 | $21.69M | Rs290.00 | -4.92% |
Figures last refreshed Oct 11, 2026.